A detailed history of Hantz Financial Services, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 449 shares of GMED stock, worth $37,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
449
Previous 353 27.2%
Holding current value
$37,918
Previous $21,000 23.81%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$51.89 - $62.79 $4,981 - $6,027
96 Added 27.2%
449 $26,000
Q2 2025

Aug 04, 2025

BUY
$55.82 - $75.5 $12,224 - $16,534
219 Added 163.43%
353 $21,000
Q1 2025

May 12, 2025

BUY
$69.68 - $93.32 $9,337 - $12,504
134 New
134 $10,000
Q3 2023

Aug 06, 2024

SELL
$49.1 - $62.37 $5,597 - $7,110
-114 Reduced 82.01%
25 $1,000
Q4 2022

Aug 06, 2024

BUY
$58.4 - $75.53 $6,657 - $8,610
114 Added 456.0%
139 $10,000
Q1 2022

Aug 06, 2024

BUY
$63.68 - $75.54 $1,592 - $1,888
25 New
25 $2,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.51B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.